{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:05:21Z","timestamp":1780319121112,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neurol.2024.10.003","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T13:47:39Z","timestamp":1730900859000},"page":"106-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adding corticosteroids to galcanezumab in medication overuse headache: A three-arm head-to-head prospective observational cohort study"],"prefix":"10.1016","volume":"181","author":[{"given":"S.","family":"Braca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stornaiuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cretella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Miele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0345-8319","authenticated-orcid":false,"given":"C.V.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurol.2024.10.003_bib0240","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(10)70008-9","article-title":"Clinical features, pathophysiology, and treatment of medication-overuse headache","volume":"9","author":"Evers","year":"2010","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2024.10.003_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"issue":"10053","key":"10.1016\/j.neurol.2024.10.003_bib0250","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.neurol.2024.10.003_bib0255","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0333102413512033","article-title":"Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review","volume":"34","author":"Westergaard","year":"2014","journal-title":"Cephalalgia"},{"issue":"9995","key":"10.1016\/j.neurol.2024.10.003_bib0260","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Global Burden of Disease Study 2013 Collaborators","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.neurol.2024.10.003_bib0265","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","article-title":"The cost of headache disorders in Europe: the Eurolight project","volume":"19","author":"Linde","year":"2012","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2024.10.003_bib0270","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(19)30146-2","article-title":"Pathophysiology, prevention, and treatment of medication overuse headache","volume":"18","author":"Diener","year":"2019","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2024.10.003_bib0275","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/WCO.0b013e328346af25","article-title":"Persistent medication-induced neural adaptations, descending facilitation, and medication overuse headache","volume":"24","author":"De Felice","year":"2011","journal-title":"Curr Opin Neurol"},{"issue":"Pt 2","key":"10.1016\/j.neurol.2024.10.003_bib0280","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/brain\/awh691","article-title":"Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine","volume":"129","author":"Fumal","year":"2006","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurol.2024.10.003_bib0285","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-022-00415-0","article-title":"Medication overuse headache","volume":"9","author":"Ashina","year":"2023","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.neurol.2024.10.003_bib0290","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41588-021-00990-0","article-title":"Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles","volume":"54","author":"Hautakangas","year":"2022","journal-title":"Nat Genet"},{"issue":"16","key":"10.1016\/j.neurol.2024.10.003_bib0295","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/0333102412461890","article-title":"Cortical response to somatosensory stimulation in medication overuse headache patients is influenced by angiotensin converting enzyme (ACE) I\/D genetic polymorphism","volume":"32","author":"Di Lorenzo","year":"2012","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.neurol.2024.10.003_bib0300","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10194-009-0136-0","article-title":"Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism","volume":"10","author":"Di Lorenzo","year":"2009","journal-title":"J Headache Pain"},{"issue":"7","key":"10.1016\/j.neurol.2024.10.003_bib0305","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/ene.12424","article-title":"Functional polymorphisms in COMT and SLC6A4 genes influence the prognosis of patients with medication overuse headache after withdrawal therapy","volume":"21","author":"Cargnin","year":"2014","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2024.10.003_bib0310","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1468-2982.2005.00879.x","article-title":"Medication overuse headache (MOH) is a biobehavioural disorder","volume":"25","author":"Saper","year":"2005","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.neurol.2024.10.003_bib0315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1129-2377-14-59","article-title":"Psychological and neuropsychological correlates of dependence-related behaviour in medication overuse headaches: a one-year follow-up study","volume":"14","author":"Radat","year":"2013","journal-title":"J Headache Pain"},{"issue":"7","key":"10.1016\/j.neurol.2024.10.003_bib0320","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1526-4610.2007.00999.x","article-title":"Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria","volume":"48","author":"Radat","year":"2008","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.neurol.2024.10.003_bib0325","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/ene.14268","article-title":"European Academy of Neurology guideline on the management of medication-overuse headache","volume":"27","author":"Diener","year":"2020","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2024.10.003_bib0330","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1212\/WNL.57.9.1694","article-title":"Clinical features of withdrawal headache following overuse of triptans and other headache drugs","volume":"57","author":"Katsarava","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2024.10.003_bib0335","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fneur.2019.00173","article-title":"Negative short-term outcome of detoxification therapy in chronic migraine with medication overuse headache: role for early life traumatic experiences and recent stressful events","volume":"10","author":"Bottiroli","year":"2019","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2024.10.003_bib0340","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1129-2377-14-10","article-title":"Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial","volume":"14","author":"Rossi","year":"2013","journal-title":"J Headache Pain"},{"issue":"9","key":"10.1016\/j.neurol.2024.10.003_bib0345","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/0333102414521508","article-title":"A consensus protocol for the management of medication-overuse headache: evaluation in a multicentric, multinational study","volume":"34","author":"Tassorelli","year":"2014","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.neurol.2024.10.003_bib0350","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/09727531231173286","article-title":"Steroids in headache: a comprehensive review of recent research","volume":"30","author":"Kashyap","year":"2023","journal-title":"Ann Neurosci"},{"issue":"1","key":"10.1016\/j.neurol.2024.10.003_bib0355","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s10194-017-0763-9","article-title":"Treatment of withdrawal headache in patients with medication overuse headache: a pilot study","volume":"18","author":"Cevoli","year":"2017","journal-title":"J Headache Pain"},{"issue":"3","key":"10.1016\/j.neurol.2024.10.003_bib0360","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/0333102412462638","article-title":"Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study","volume":"33","author":"Rabe","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2024.10.003_bib0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.npep.2015.03.008","article-title":"Up-regulation of calcitonin gene-related peptide in trigeminal ganglion following chronic exposure to paracetamol in a CSD migraine animal model","volume":"51","author":"Yisarakun","year":"2015","journal-title":"Neuropeptides"},{"issue":"3","key":"10.1016\/j.neurol.2024.10.003_bib0370","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.21897","article-title":"Triptan-induced latent sensitization: a possible basis for medication overuse headache","volume":"67","author":"De Felice","year":"2010","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2024.10.003_bib0375","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/0333102420966658","article-title":"Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine","volume":"41","author":"Dodick","year":"2021","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.neurol.2024.10.003_bib0380","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s10194-020-01173-8","article-title":"The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study","volume":"21","author":"Silberstein","year":"2020","journal-title":"J Headache Pain"},{"issue":"20","key":"10.1016\/j.neurol.2024.10.003_bib0385","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.1212\/WNL.0000000000007497","article-title":"Erenumab in chronic migraine with medication overuse: subgro*up analysis of a randomized trial","volume":"92","author":"Tepper","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2024.10.003_bib0390","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/head.14036","article-title":"Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: subgroup analysis of PROMISE-2","volume":"61","author":"Diener","year":"2021","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.neurol.2024.10.003_bib0395","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/head.14528","article-title":"A head-to-head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene-related peptide for chronic and episodic migraine","volume":"63","author":"Sacc\u00e0","year":"2023","journal-title":"Headache"},{"issue":"6 Suppl. 1","key":"10.1016\/j.neurol.2024.10.003_bib0400","first-page":"S20","article-title":"Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability","volume":"56","author":"Stewart","year":"2001","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurol.2024.10.003_bib0405","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10194-010-0221-4","article-title":"Medication overuse headache: a critical review of end points in recent follow-up studies","volume":"11","author":"Hagen","year":"2010","journal-title":"J Headache Pain"},{"issue":"7","key":"10.1016\/j.neurol.2024.10.003_bib0410","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11910-023-01278-y","article-title":"Medication overuse headache: an updated review and clinical recommendations on management","volume":"23","author":"Hird","year":"2023","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"10.1016\/j.neurol.2024.10.003_bib0415","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0333102417737779","article-title":"Complete detoxification is the most effective treatment of medication-overuse headache: a randomized controlled open-label trial","volume":"38","author":"Carlsen","year":"2018","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.neurol.2024.10.003_bib0420","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/ejp.1383","article-title":"Complete withdrawal is the most feasible treatment for medication-overuse headache: a randomized controlled open-label trial","volume":"23","author":"Engelstoft","year":"2019","journal-title":"Eur J Pain"},{"issue":"2","key":"10.1016\/j.neurol.2024.10.003_bib0425","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-2982.2000.00028.x","article-title":"Prednisone as initial treatment of analgesic-induced daily headache","volume":"20","author":"Krymchantowski","year":"2000","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.neurol.2024.10.003_bib0430","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","article-title":"Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study","volume":"27","author":"Diener","year":"2007","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.neurol.2024.10.003_bib0435","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1468-2982.2008.01711.x","article-title":"Management of medication overuse headache: 1-year randomized multicentre open-label trial","volume":"29","author":"Hagen","year":"2009","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1016\/j.neurol.2024.10.003_bib0440","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1468-2982.2009.01859.x","article-title":"Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse","volume":"29","author":"Diener","year":"2009","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.neurol.2024.10.003_bib0445","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/brain\/awz052","article-title":"Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial","volume":"142","author":"Pijpers","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurol.2024.10.003_bib0450","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0333102415593088","article-title":"Treatment of medication-overuse headache: a systematic review","volume":"36","author":"Chiang","year":"2016","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.neurol.2024.10.003_bib0455","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamaneurol.2020.1179","article-title":"Comparison of 3 treatment strategies for medication overuse headache: a randomized clinical trial","volume":"77","author":"Carlsen","year":"2020","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2024.10.003_bib0460","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/03331024211067791","article-title":"Detoxification vs. non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache","volume":"42","author":"Pensato","year":"2022","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1016\/j.neurol.2024.10.003_bib0465","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1046\/j.1468-2982.2003.00648.x","article-title":"Out-patient detoxification in chronic migraine: comparison of strategies","volume":"23","author":"Krymchantowski","year":"2003","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.neurol.2024.10.003_bib0470","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/01.wnl.0000263652.46222.e8","article-title":"Prednisolone does not reduce withdrawal headache: a randomized, double-blind study","volume":"69","author":"B\u00f8e","year":"2007","journal-title":"Neurology"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378724006246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378724006246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T19:33:47Z","timestamp":1737574427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378724006246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0035378724006246"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2024.10.003","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adding corticosteroids to galcanezumab in medication overuse headache: A three-arm head-to-head prospective observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2024.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}